Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

Tick bites can cause hair loss similar to alopecia areata, and baricitinib may help regrow hair.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Topical calcipotriol may help treat alopecia areata, especially in those with low vitamin D.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

A woman got male pattern baldness from touching her husband's testosterone gel.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

An elderly Chinese man lost all his hair after taking a new heart medication.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.